Prof. Dr. Michael Hallek - Curriculum Vitae
Education and Professional Career
2018 – 2022: Founding chairman 2018-2022 CIO Aachen Bonn Cologne Düsseldorf
since 2007: Director, Center for Integrated Oncology (CIO), University of Cologne
since 2003: C4-Professor, University of Cologne, Department of Internal Medicine
1999 – 2003: C3-Professor, University of Munich
1998 – 2005: Head, Clinical Cooperation Group GSF (Helmholtz-Institute) Munich
1998: Board examination hematology and oncology
1996: Board examination internal medicine
1995 – 2003: Senior Consultant, University of Munich
1995: Habilitate, University of Munich
1994 – 2005: Research Group Leader, Gene Center Munich
1990 – 1992: Research Associate, Dana Farber Cancer Institute, Harvard Medical School, USA
1986: MD Thesis, University of Munich
1985: Graduation from Medical School, Technical University Munich
1985 – 2003: Training in pharmacology, internal medicine, hematology and oncology, Technical University of Munich and University of Munich
1978 – 1985: Medical School, University of Regensburg and Technical University Munich
Awards, Distinctions and Scientific Activities
since 2023: Chairman, Council for Health and Care of the Federal Government (Sachverständigenrat der Bundesregierung)
since 2022: Speaker, CRC 1530 on Elucidation and targeting of pathogenic mechanisms in B cell malignancies
since 2022: Chairman, Scientific Board of the German Chamber of Physicians
since 2021: Member, Scientific Council of the German Government (Wissenschaftsrat)
since 2020: Associate Editor of Blood
since 2019: Strategy Advisory Board “National Decade against Cancer”, Federal Ministry of Education and Research (BMBF)
since 2019: President, Walter-Siegenthaler Society
since 2018: Chairman Scientific Committee, European School of Hematology, Paris
2016 – 2019: Chairman, German Society of Hematology and Oncology (DGHO)
since 2016: Member of the Medical Committee of the German Scientific Council (Wissenschaftsrat) of the German Government
2013 – 2021: Chairman, Clinical Research Unit 286 “DNA damage response in CLL”
since 2011: Member of the National Academy of Sciences Leopoldina
2009 – 2014: Chairman, Collaborative Research Center 832 on “Tumor Microenvironment”
since 2000: Scientific Committee (Core Group) International Working Group on CLL (iwCLL)
since 1996: Founder and Chairman, German CLL Study Group